| scholarly article | Q13442814 |
| P356 | DOI | 10.2350/14-10-1566-OA.1 |
| P698 | PubMed publication ID | 25490715 |
| P50 | author | Miguel Reyes-Múgica | Q90616688 |
| P2093 | author name string | Lorelei J Grunwaldt | |
| Donald Johnson | |||
| Bruce S Bauer | |||
| Cláudia M Salgado | |||
| Dipanjan Basu | |||
| Veronica Rundell | |||
| Marina Nikiforova | |||
| P2860 | cites work | RAS oncogenes: weaving a tumorigenic web | Q28250360 |
| Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases | Q28307906 | ||
| BRAFE600-associated senescence-like cell cycle arrest of human naevi | Q29619550 | ||
| Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi | Q33976060 | ||
| Melanoma risk in congenital melanocytic naevi: a systematic review | Q33997045 | ||
| Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis | Q34031334 | ||
| New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. | Q34033621 | ||
| RAS Interaction with PI3K: More Than Just Another Effector Pathway | Q34202692 | ||
| Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. | Q34299790 | ||
| Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies | Q34716617 | ||
| Small-molecule modulation of Ras signaling | Q35188280 | ||
| Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development | Q36098992 | ||
| MR of leptomeningeal melanosis in children | Q36684918 | ||
| Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS | Q36919636 | ||
| A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples | Q41703846 | ||
| Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations | Q44687199 | ||
| Vemurafenib for leptomeningeal melanomatosis. | Q45941209 | ||
| Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi | Q47769824 | ||
| Neurocutaneous melanosis is associated with tethered spinal cord | Q48606837 | ||
| Neurocutaneous melanosis in children with giant congenital melanocytic nevi | Q48870239 | ||
| NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. | Q54239316 | ||
| Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population. | Q54601653 | ||
| Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. | Q54641558 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2014-12-09 | |
| P1433 | published in | Pediatric and Developmental Pathology | Q15758754 |
| P1476 | title | BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. | |
| P478 | volume | 18 |
| Q33731436 | Biologically distinct subsets of nevi |
| Q103020082 | Clinical Follow Up of Patients with Neurocutaneous Melanosis in a Tertiary Center; Proposed Modification in Diagnostic Criteria |
| Q92180963 | Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi |
| Q91770898 | Epilepsy in isolated parenchymal neurocutaneous melanosis: A systematic review |
| Q55416297 | Implementation of cell-free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report. |
| Q43132421 | Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis? |
| Q33835568 | Melanoma in congenital melanocytic naevi. |
| Q36083348 | NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications |
| Q28070020 | Neurocutaneous Manifestations of Genetic Mosaicism |
| Q39211838 | Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway |
| Q42736226 | Prepubertal Melanoma Arising within a Medium-Sized Congenital Melanocytic Nevus |
| Q38297995 | Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects |
| Q53150017 | Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. |
| Q52898065 | The High Multiplicity of Prenatal (Congenital Type) Nevi in Adolescents and Adults. |
| Q35822379 | Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting |
| Q39755837 | Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size |
Search more.